Emerging Infectious Disease Testing Technologies and Market Applications

September 2011 | 61 pages | ID: IB71DFEF154EN
Venture Planning Group

Abstracts

This report provides a detailed analysis of the current and emerging technologies, and their potential applications for the infectious disease testing market, including DNA probes, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several others.

Contains 61 pages

Contents

1. DNA PROBES

a. Technology Overview
b. Amplification Methods
  Polymerase Chain Reaction
  Robotics
  Temperature Cyclers
  PCR Variations
  Immuno-PCR
  QC-PCR
  DAP-PCR
  Ligase Chain Reaction
  Branched DNA
  Q-Beta Replicase
  Nucleic-Acid Sequence-Based
  Strand Displacement Activation
  Self-Sustained Sequence Replicase

2. MONOCLONAL ANTIBODIES

3. IMMUNOASSAYS

a. Technological Principle
b. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  Dot Immunobinding Assays
  Capillary Immunoassays
  Particle-Membrane Capture Immunoassays
  Enzyme Amplification
c. Fluorescent Immunoassays
  Fluorescence Polarization
  Time-Resolved Pulse Fluorescence
d. Luminescence
  Chemiluminescence
  Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation

4. DIFFERENTIAL LIGHT SCATTERING

5. MICROCOMPUTERS AND AUTOMATION

6. ARTIFICIAL INTELLIGENCE

7. LIPOSOMES

8. FLOW CYTOMETRY

9. CHROMATOGRAPHY

10. MRI

11. GEL MICRODROPLETS

12. OTHER